iHealthConnections, Volume 1 Issue 1
iHealth Connections provides a trusted platform to explore the issues and the driving forces behind this emerging trend. From strategic frameworks to decisions on managing investment and considering various scenarios for the convergence pathway, expert authors who are uniquely positioned across the sectors willprovide their perspectives on the solutions that will enable this transformation.
The inaugural issue of the journal included a superb expert opinion piece written by Rebecca Kush on ‘Transforming Medical Research with Electronic Health Records.’Furthermore, a comment piece by H Stephen Lieber offered an intuitive look into Health Technology Implementation.
Click here to access iHealthConnections – Volume 1.1
iHealthConnections, Volume 1 Issue 2
In the latest issue Charles Jaffe contributes an excellent paper, ‘Use of Patient Level Data forBiomedical Research—Path to Interoperability,’ while an interview with David B Nash offers an insightful angle on the impact of health reform. Elsewhere in this edition, Andreas Schmidt and colleaguesprovide a fascinating discussion on the EHR4CR Project – A European Survey on Electronic Health Records Systems for Clinical Research.
Click here to access iHealthConnections – Volume 1.2
Late Phase Development: Maximizing the Value of Real World Data
There is increasing recognition that data obtained under the tightly controlled settings of clinical trials do not necessarily reflect actual experience in clinical practice. At the same time, late phase development data have been recognized as important alternative information sources that reflect an uncontrolled real-world setting, complementing and expanding on clinical trial findings. Drivers for the growing importance of late phase development data include the increasingly stringent post-marketing regulatory environment, the move towards proactive pharmacovigilance, and the rise of comparative effectiveness research. The series of papers in this report will provide focused discussion on the challenges and benefits of late phase studies. The topics will include the major factors that must be addressed to ensure a successful late phase development strategy for novel medical interventions. The value propositions, the regulatory hurdles, and operational challenges will also be discussed with clear examples of best practices for optimization.
Click through to: Late Phase Development: Maximizing the value of real world data
To access the current edition in full and free eBook format, please click through to: Late Phase Development Ejournal
For more information please visit: www.touchhealthsciences.com
Drug Development – Volume 5
Health Sciences Visions from Touch Briefings
‘Touch Briefings announces launch of a new eHealthcare report — Patient Management without Walls'
Pharmaceutical Business Review
CDISC is pleased to collaborate with Pharmaceutical Business Review (PBR). PBR websites have all the latest news, comment and industry information. Each Business Review website offers content that is produced by a dedicated team of journalists and global industry experts.